Century Therapeutics (IPSC) Current Assets (2020 - 2026)

Century Therapeutics (IPSC) has reported Current Assets for 7 consecutive years, with $139.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Current Assets fell 18.03% year-over-year to $139.0 million; the TTM figure through Mar 2026 stood at $139.0 million (down 18.03% YoY), while the FY2025 annual figure was $120.8 million, down 37.76% from the prior year.
• Current Assets rose to $139.0 million in Q1 2026 per IPSC's latest filing, from $120.8 million in the prior quarter.
• Across five years, Current Assets topped out at $383.8 million in Q2 2022 and bottomed at $120.8 million in Q4 2025.
• Historically, Current Assets has averaged $219.4 million across 5 years, with a median of $194.1 million in 2024.
• Annual changes were most pronounced in 2022 — Current Assets soared 40.13% — and 2023, when it plunged 57.98%.
• Century Therapeutics' Current Assets stood at $319.7 million in 2022, then slumped by 44.64% to $177.0 million in 2023, then advanced by 9.64% to $194.1 million in 2024, then sank by 37.76% to $120.8 million in 2025, then increased by 15.13% to $139.0 million in 2026.
• Business Quant data shows IPSC's Current Assets at $139.0 million in Q1 2026, $120.8 million in Q4 2025, and $137.7 million in Q3 2025.